[Report de-identified (Safe-harbor compliant) by De-ID v.6.22.08.0]


**INSTITUTION PALLIATIVE CARE PROGRESS NOTE
- - - - -
DATE: **DATE[Nov 03 2009]
Time: 13:27
- - - - -
Physical: Pt non-verbal and non-responsive.  Pt's son at bedside.  Son reports
pt has not been interactive or verbal in his presence this morning.  Pt has not
eating anything orally over last two days.  Son notes goals of having pt return
to walking and eating.  Son notes pt's breathing pattern has changed **DATE[Nov 03 2009]
from yesterday.  Today, pt is having intermittent changes in respiratory rate
where he will breath quickly for a time and then breath more shallowly for a
period of time.  Pt's son believes the pt is comfortable.    
- - - - -
REVIEW OF SYSTEMS:  Modified Edmonton System Assessment Scale (ESAS): This
control requires a parameter in the Form Designer tool called 'FormName'.
For more information, refer tot he Forms Development Guide. 
- - - - -
GENERAL EXAM (Select "not examined" for any organ system not examined because
such examination is not medically necessary for this encounter)

Rounding Report Vitals: VITALS TIME:**DATE[Nov 03 2009] 13:28
VITALS:
**DATE[Nov 03] 04:30 T:      BP:151/69 P: 97 RR: 20 SaO2: 96 FiO2:  5 Ht:      Wt:     
**DATE[Nov 03] 00:00 T:      BP:133/82 P:100 RR: 24 SaO2: 99 FiO2:  5 Ht:      Wt:     
**DATE[Nov 02] 22:30 T:      BP:133/75 P: 97 RR: 20 SaO2: 99 FiO2:  5 Ht:      Wt:     
**DATE[Nov 02] 20:00 T: 37.0 BP:       P:    RR:    SaO2:    FiO2:    Ht:      Wt:     
24 Hr Max Temp:37.0
36 Hr Max Temp:37.0
- - - - -
Constitutional: No acute distress
Eyes:  Other: eyes closed
Ears, Nose, Mouth & Throat:  Other: dry oral mucosa
Respiratory:  Other: decreased breath sounds bilaterally; 30 second periods of
apnea intermixed with periods of tachypnea
Cardiovascular: RRR; Normal S1, S2; No murmur
Gastrointestinal: Soft; Nontender;  Other: decreased BS
Extremities:  Other:  (attending): erythema bilateral anterior shins; trace
edema BLE
Neurologic:  Other: does not awake to voice or soft touch; not following
commands
Integumentary/Skin: No Rash; No Jaundice;  Other: eccymosis central chest
Musculoskeletal: Not examined
Genitourinary: Not examined
Rectal/Pelvic: Not examined
Breasts: Not examined
Hematologic, Lymphatic & Immunologic: Not examined
- - - - -
Labs: Reviewed
- - - - -
ROUNDING REPORT: ATTENDING:**NAME[ZZZ, YYY M]
SERVICE:General Medicine
CODE STATUS:Code Status  -  Limited Therap
ISOLATION STATUS:C Diff & VRE
ALLERGIES:Fosamax
ROUNDING REPORT TIME:**DATE[Nov 03 2009] 13:28
VITALS:
**DATE[Nov 03] 04:30 T:      BP:151/69 P: 97 RR: 20 SaO2: 96 FiO2:  5 Ht:      Wt:     
**DATE[Nov 03] 00:00 T:      BP:133/82 P:100 RR: 24 SaO2: 99 FiO2:  5 Ht:      Wt:     
**DATE[Nov 02] 22:30 T:      BP:133/75 P: 97 RR: 20 SaO2: 99 FiO2:  5 Ht:      Wt:     
**DATE[Nov 02] 20:00 T: 37.0 BP:       P:    RR:    SaO2:    FiO2:    Ht:      Wt:     
24 Hr Max Temp:37.0
36 Hr Max Temp:37.0
IO:        (7a-3p) (3p-12a) (12a-7a)    Total  (7a-3p) (3p-12a) (12a-7a)
INTAKE:        **PHONE     1300     3220        0        0        0
OUTPUT:       1100      250      325     1675        0        0        0
BALANCE:      -**PHONE      975     1545        0        0        0
MEDICATIONS:
ACTIVE INPATIENT MEDICATION ORDERS
aspirin   81mg  By Mouth Daily
cholecalciferol   400IU  By Mouth Daily
D5 1/2NS 1000 mL 5%   1000mL 100mL/hr IV
docusate (Colace)   100mg  By Mouth BID
famotidine (Pepcid)   20mg  IV Q24H
furosemide   20mg  IV Daily
heparin   5,000Unit(s)  subQ Q8H
isosorbide dinitrate   5mg  By Mouth BID
levothyroxine (Synthroid)   75mcg  By Mouth QAM
lisinopril   2.5mg  By Mouth Daily
metoprolol   100mg  By Mouth BID
metronidazole (Flagyl)   500mg  IV Q6H
multivitamin (Theragran)   1tab(s)  By Mouth Daily
niacin   250mg  By Mouth BIDmeals
phenytoin (Dilantin injection)   100mg  IV Q8H
potassium chloride   20mEq  Duotube BID
senna   10mL  By Mouth AtBedtime
ACTIVE INPATIENT PRN MED ORDERS
acetaminophen   650mg  By Mouth Q4H
acetaminophen   650mg  Per Rectum Q4H
albuterol 0.083% (albuterol 0.083% inh...   2.5mg  Aerosol Q4H
calcium carbonate (Tums)   500mg  By Mouth QID
glycopyrrolate (Robinul)   0.2mg  IV Q4H
hydrALAZINE (Apresoline)   10mg  IV Q10Min
labetalol   10mg  IV Q10Min
magnesium sulfate   8gm  IV As DirCPOE
nitroglycerin   0.4mg  Sublingual Q5Min
ondansetron (Zofran)   4mg  IV Q6H
ONE TIME MED ORDERS
**DATE[Nov 02] 22:25phenytoin (Dilantin injection)   1,000mg  IV ONCE
LABS:
**DATE[Nov 03] 08:10
Phenytoin (adjusted) 17.42
Phenytoin 10.8
**DATE[Nov 03] 05:00
Anion Gap 8.0
GFR (estimated) eGFR L
Ca (adjusted) 8.5
Na 143
K 3.3 L
Cl 103
CO2 32 H
BUN 27 H
Cr 1.2
Glucose 194 H
Ca 7.7 L
Mg 2.5 H
Phos 2.8
Albumin 2.6 C
Total Protein 5.2 L
Bili, Total 1.0
Bili, Direct 0.2
ALT/SGPT 31
AST/SGOT 43 H
Alk Phos 55
Prealbumin 14 L
WBC 9.0
RBC 3.77 L
Hgb 11.4 L
Hct 34.1 L
MCV 90.6
RDW 16.1 H
Platelets 149 L
Neutrophils 89 H
Lymphs 5 L
Monocytes 6
Eosinophils 0
Basophils 0
Type of Differential Automated Differential
PT 17.5 H
INR 1.4 H
PTT 31.7
**DATE[Nov 03] 04:30
Urine Volume >10
Appearance, Urine Hazy
Color, Urine Yellow
Urine pH 5.5
Specific Gravity, Urine 1.019
Bilirubin, Urine Neg
Blood, Urine 1+ A
Ketones, Urine Neg
Leukocyte Esterase, Urine 2+ A
Nitrite, Urine Neg
Urine Protein, Qual 30 A
Urine Glucose, Qual Neg
Urine Urobilinogen Normal
WBC, Urine >182 H
RBC, Urine 31 H
Squamous Epithelial Cells, Urine 1
Bacteria, Urine None
WBC Clumps, Urine Occasional A
Mucus, Urine Rare A
**DATE[Nov 02] 04:05
pHa 7.49 H
PaCO2 40
PaO2 96
HCO3a 31 H
Base Excess, Arterial 7 H
**DATE[Nov 02] 03:40
Anion Gap 9.0
GFR (estimated) eGFR L
Ca (adjusted) 8.8
Na 145
K 3.8
Cl 108 H
CO2 28
BUN 24
Cr 1.2
Glucose 99
Ca 7.9 L
Mg 2.6 H
Phos 3.1
Albumin 2.5 C
Total Protein 5.2 L
Bili, Total 1.0
Bili, Direct 0.2
ALT/SGPT 31
AST/SGOT 47 H
Alk Phos 50
WBC 8.1
RBC 3.73 L
Hgb 11.4 L
Hct 33.3 L
MCV 89.2
RDW 15.6 H
Platelets 196
Neutrophils 88 H
Lymphs 5 L
Monocytes 6
Eosinophils 1
Basophils 0
Type of Differential Automated Differential
PT 16.6 H
INR 1.3 H
PTT 30.1
TSH 4.558
B-Type Natriuretic Peptide 683 H
**DATE[Nov 02] 01:00
Urine Volume >10
Appearance, Urine Clear
Color, Urine Yellow
Urine pH 5.5
Specific Gravity, Urine 1.023
Bilirubin, Urine Neg
Blood, Urine Neg
Ketones, Urine Trace A
Leukocyte Esterase, Urine 1+ A
Nitrite, Urine Neg
Urine Protein, Qual 30 A
Urine Glucose, Qual Neg
Urine Urobilinogen Normal
WBC, Urine 6 H
RBC, Urine 2
Squamous Epithelial Cells, Urine <1
Bacteria, Urine Moderate A
Mucus, Urine Rare A
MICROBIOLOGY:
VRE SCREEN(Rectal Swab)  9/28.   Culture: Rare ENTEROCOCCUS FAECIUM Positive for Vancomycin Resistant Enterococci (VRE) Vancomycin MIC = >256.0 **INITIALS For epidemiological purposes only. Positive cultures represent VRE colonization which does not require treatment.  [Final]
DVT Prophylaxis:Heparin
GT Prophylaxis:Famotidine
ASSESSMENT AND PLAN
Assessment: patient with new mental obtundation after a SAH and respiratory arrest. Family do not want to rush to stop aggressive therapy and end up shortening his life and not give him any quality of life.
- - - - -
Problem/Diagnosis 1: Upper airway secretions; Plan: Resolved. Likely due to poor ability to clear oral secretions due to decreased mental status.  Would continue Robinul 0.2mg IV q4h prn
Problem/Diagnosis 2: Mental Status change; Plan: Pt's poor neuro status continues--pt non-verbal, not interactive or following commands.  DDx includes hypoxia, traumatic brain injury from SAH. Pt not on sedating medications, phenytoin level wnl.  Would continue to minimize sedating medications.
Problem/Diagnosis 3: Goals of care; Plan: Code status DNR/DNI.  Family wishes to give pt more time to recover neurologically.  They wish to continue current measures for now.  
- - - - -
ATTENDING NOTE AND ATTESTATION: Non-time based
- - - - -
ATTENDING PHYSICIAN SIGNATURE: Electronically signed by **NAME[WWW XXX], MD at 13:44; **NAME[XXX, WWW] ; 10454; **DATE[Nov 03 2009]; 13:44
- - - - -
VISIT CODE(S): 99231; No Resident/**NAME[VVV] Involvement
- - - - -


https://salarcp:**EMAIL/cerner/get_pdf.php?rowguid=c7bdb8da-df8a-4653-be15-0cf535fad923^URL^IMAGE